Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • chronic

    Tag: chronic

    You Searched For "chronic"
    Cipla launches respiratory inhalation therapy product Niveoli in India

    Cipla launches respiratory inhalation therapy product Niveoli in India

    Farhat Nasim12 April 2019 11:41 AM IST
    New Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
    AstraZeneca gets EU nod to diabetes drug Forxiga

    AstraZeneca gets EU nod to diabetes drug Forxiga

    Medical Dialogues Bureau27 March 2019 2:55 PM IST
    Farxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Cipla to launch Cinacalcet Hydrochloride tablets, a generic version of Sensipar

    Farhat Nasim7 March 2019 9:30 AM IST
    Cipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a...
    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    Medical Dialogues Bureau12 May 2018 12:00 PM IST
    The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok